Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin vs Colistin plus Rifampicin in MDR P. aeruginosa and A. baumannii
NCT01297855Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in Acinetobacter baumannii infection, Pseudomonas aeruginosa infection, sponsored by Mahidol University. Status: unknown.
02
Drugs
rifampicin
03
Conditions
Acinetobacter baumannii infectionPseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01297855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297855.